Pharmacokinetics Flashcards

1
Q

what is pharmacokinetics

A

the study of the time course of drug concentration in the body, usually as reflected in the plasma concentration (fate of drug in the body).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

first order kinetics is also referred to as what

A

exponential kinetics characterized by a constant fractional change per unit time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

first order kinetics is measured as what

A

the rate constant (Ke)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

zero order kinetics is also referred to as what

A

saturation kinetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

first order kinetics is characterized by what

A

a constant amount of change per unit time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

half-time or biological half life (t 1/2)

A

for drugs that are eliminated by first-order kinetics, the fractional change in the amount of drug in the blood is generally expressed by the half-life. Time required for 50% of the drug remaining in the body to be eliminated (or the time required for the blood concentration to decrease 50%).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

rate constant of elimination (Ke)

A

For drugs that are eliminated by first-order kinetics, the rate constant is the fractional change per unit time (fraction/min, fraction/hour, etc)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

rate constant of elimination (Ke) is equal to what

A

0.693 / t1/2
OR
t1/2 = 0.693/ke

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is clearance

A

the quantification of elimination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

for most drugs in clinical setting, clearance is

A

constant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

clearance represents the volume of

A

biological fluid that would have to be completely freed of drug to account for the rate of elimination (ie. the volume of body fluid processed in a given time)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

clearance is expressed as

A

volume per unit time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

individual organ clearances are

A

additive

ie. take renal cl, pulmonary cl etc. and add the volumes up to give you total systemic clearance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

clearance can be calculated from what

A
  1. excretion rate/concentration

2. dose/area under the curve (AUC)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

compartmental model of pharmacokinetics

A

uses selected model to “fit” parameters to data

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

noncompartmental model of pharmacokinetics

A

most use the same basic principles (Trapezoidal rule; observed data; calculated elimination rate constant; standard formulas for the rest)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Fate of a drug

A
  1. liberation
  2. absorption
  3. distribution
  4. metabolism
  5. excretion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what is liberation

A

release from matrix

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what is absorption

A

process and rate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what is distribution

A

movement in body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

what is metabolism

A

removal by biotransformation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

what is excretion

A

physical removal from body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

what are key pharmacokinetic parameters

A
  • clearance
  • volume of distribution
  • half-life
  • bioavailability
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

what is volume of distribution

A

concept for a given dose, the theoretical size necessary to produce a specific calculated exposure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

what is half-life

A

the length of time necessary to reduce or “eliminate” 50% of the current level of drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

what is bioavailability

A

the fraction of the dose that reaches systemic circulation

f=1 for IV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

assumptions of a one compartment model

A
  • the body is a single compartment with a volume (V) and drug concentration (C)
  • distribution of drug is uniform and rapid compared with absorption and elimination
  • elimination of the drug conforms to 1st order kinetics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

see diagram: slide 10-11

A

see diagram: slide 10-11

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

assumptions of a two compartment model

A
  • the body contains 2 compartments, central and peripheral
  • all kinetics are first order
  • elimination is form the central compartment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

see diagram: slide 12 + 13

A

see diagram: slide 12 + 13

31
Q

what are model independent parameters

A
  • clearance, half-life, Vd
  • AUC
  • Cmax (max concentration)
  • Tmax (time of max concentration)
32
Q

see calculations: slide 16

A

see calculations: slide 16

33
Q

what is the plateau principle

A
  • when a drug is administered intravenously, the plasma concentration will increase until the rate of elimination and administration are equal
  • at that point, the plasma drug [ ] will remain constant until there is a change in the dosage rate of elimination kinetics
34
Q

steady state concentration (Css) equation

A

rate of administration/total body Cl = dosing rate/Cl

35
Q

dosing rate equals

A

Cl x Css

36
Q

Css equals

A

dosing rate/Cl

37
Q

see diagram: slide 19

A

see diagram: slide 19

38
Q

time required to achieve steady state depends on

A

half life

39
Q

how many half lives does it take to achieve steady state

A

4-6 half-lives

40
Q

see diagram: slide 21

A

see diagram: slide 21

41
Q

conditions for fixed rate, multiple doses

A
  • the drug will accumulate in the body if the time interval between doses is less than 4 half lives
  • total body stores of the drug increase exponentially to a plateau
  • the plasma [ ] will fluctuate during the dosing interval
  • Css now represents the mean [ ] of the drug during the dosing interval
42
Q

for oral dosing, what will also influence Css

A

bioavailability

43
Q

what is bioavailability

A

is the fraction (f) of the administered dose that reaches the systemic circulation

44
Q

what is the equation of Css in a fixed rate, multiple dose regimen

A

Css = (f) x dose / (dosing interval x Cl)

45
Q

what happens to the [plasma] with a fixed rate multiple dose regimen

A

[plasma] will fluctuate btwn a maximum (peak) and a minimum (trough) concentration

46
Q

see diagram: slide 24

A

see diagram: slide 24

47
Q

for therapy characterized by repeated intermittent dosing, the choice of dosage interval is based on what

A
  • tolerance btwn dose variations of serum concentraions (based on half life and toxicity of the drug)
  • patient convenience plays a role for out patient therapy
48
Q

when would a loading dose be administered

A

when the time to reach steady state is needed immediately

49
Q

the amount of drug required to achieve a given steady-state value in plasma is the amount that

A

must be in the body when the desired steady-state is reached

50
Q

what variable relates the total drug [ ] in the body to the plasma [ ]

A

Vd

51
Q

loading dose equation is

A

loading dose = Css x Vd

52
Q

what is nonlinear, dose-dependent or saturable elimination kinetics

A

a capacity-limited process where drugs exceed the metabolic/excretory capacity of the body to eliminate that drug as a linear rate

53
Q

describe the clearance rate of a nonlinear elimination

A

Cl will vary with the [ ] of drug in a manner analogous to the M-M equation for enzyme kinetics

54
Q

virtually all drugs taken by pregnant women are transferred to some degree across the

A

placenta to the fetus

55
Q

delivery of single doses in pregnant women is limited by what

A

blood flow to the placenta

56
Q

when does peak fetal blood concentration occur

A

btwn 20 mins and 4 hrs after IV dosing depending on the chemical characteristics of the drug

57
Q

chronic dosing during pregnancy can lead to what

A

a steady-state

fetal:maternal [ ] approach unity

58
Q

what are 5 critical time frames of pediatric pharmacology

A
  1. conception to birth
  2. birth to 1 month
  3. 1 month to 2 yrs
  4. 2 years to 12 yrs
  5. 12 yrs to 18 yrs
59
Q

what drug characteristics affect developmental factors

A
  • drug absorption
  • drug distribution/% body water
  • drug metabolism
  • drug excretion
60
Q

dosages are determined by

A
  • formula

- body to surface area

61
Q

drug disposition and aging is determined by what

A
  • absorption
  • distribution
  • drug metabolism
62
Q

how is absorption affect by age

A

relatively normal

63
Q

how is distribution affect by age

A

aging is characterized by decreased lean body mass, increased % of body weight represented as fat, and decreased total body water

64
Q

how is drug metabolism affected by age

A

-slower on average in the elderly due to decreased hepatic blood flow and smaller liver size

65
Q

does the aging liver decreases its metabolism for all drugs

A

the aging liver to metabolize drugs does not decline in a similar way for all pharmacological agents, and the clearance of some drugs is largely unchanged (depends on intrinsic Cl)

66
Q

what is the cockroft-gault equation

A
  • estimates the glomerular filtration rate and generally

- obtained by estimating endogenous creatine clearance

67
Q

what is cockroft-gault equation

A

CreatineCl = [140-age] [weight] / (72 x serumcr in mg/dL)

68
Q

for women, creatinine clearance is –% of the value calculated by the Cockroft-Gault eqn

A

85%

69
Q

why might the GRF be overestimated using the Cockroft-Gault eqn in older individuals with low [ ]

A

bc endogenous creatinine production from muscle is decreasing with age

70
Q

how does age affect renal excretion

A

-aging is associated with decreased renal size and renal blood flow, leading to decreases in glomerular filtration rate

71
Q

decreases in tubular function parallel those in

A

glomerular function

72
Q

based on cross-sectional studies, creatinine clearance decreases an average of

A

8ml/min/decade after age 30

73
Q

what dosage adjustments are done for renal dysfunction

A
  1. decrease dose, but maintain dosage interval

2. maintain dose, but increase length of dosage intervals

74
Q

when is decreasing dose the preferred method of dosage adjustment for renal dysfunction

A

when a relatively constant plasma concentration of the drug is desired